{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:22:59Z","timestamp":1786990979808,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560270"],"award-info":[{"award-number":["81560270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.intimp.2020.106255","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T17:19:10Z","timestamp":1580404750000},"page":"106255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Elevated levels of soluble Endothelial protein C receptor in rheumatoid arthritis and block the therapeutic effect of protein C in collagen-induced arthritis"],"prefix":"10.1016","volume":"81","author":[{"given":"Li","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengnian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangrui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.106255_b0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrrheum.2017.205","article-title":"Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis","volume":"14","author":"Bouta","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106255_b0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2020.106255_b0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","article-title":"Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis","volume":"19","author":"Bustamante","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2020.106255_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/08830185.2016.1269175","article-title":"Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: Current status and future directions","volume":"36","author":"Ganesan","year":"2017","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.106255_b0025","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2020.106255_b0030","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1186\/ar3168","article-title":"Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis","volume":"12","author":"Cascao","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2020.106255_b0035","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106255_b0040","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.21342","article-title":"Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis","volume":"52","author":"Koenders","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.106255_b0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","article-title":"Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?","volume":"77","author":"Baker","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2020.106255_b0050","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.20170494","article-title":"Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets","volume":"214","author":"Fang","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2020.106255_b0055","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/kep028","article-title":"Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis","volume":"48","author":"Nistala","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2020.106255_b0060","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2014-05-578328","article-title":"Endothelial cell protein C receptor: a multiliganded and multifunctional receptor","volume":"124","author":"Mohan Rao","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.106255_b0065","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1160\/TH11-11-0766","article-title":"Is EPCR a multi-ligand receptor? Pros and cons","volume":"107","author":"Montes","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.intimp.2020.106255_b0070","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1073\/pnas.93.19.10212","article-title":"The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex","volume":"93","author":"Stearns-Kurosawa","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2020.106255_b0075","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/blood-2005-06-2249","article-title":"Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow","volume":"107","author":"Balazs","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.106255_b0080","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/nm.3960","article-title":"PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells","volume":"21","author":"Gur-Cohen","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2020.106255_b0085","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1136\/ard.2006.068239","article-title":"Endothelial protein C receptor is overexpressed in rheumatoid arthritic (RA) synovium and mediates the anti-inflammatory effects of activated protein C in RA monocytes","volume":"66","author":"Xue","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2020.106255_b0090","article-title":"Mac-1 directly binds to the endothelial protein C-receptor: a link between the protein C anticoagulant pathway and inflammation?","volume":"e53103","author":"Fink","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2020.106255_b0095","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1096\/fj.09-134445","article-title":"Activated protein C utilizes the angiopoietin\/Tie2 axis to promote endothelial barrier function","volume":"24","author":"Minhas","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2020.106255_b0100","doi-asserted-by":"crossref","first-page":"xviii-xix","DOI":"10.1111\/j.0022-202X.2005.23975.x","article-title":"Further evidence of multifunctionality in the keratinocyte: the endothelial protein C receptor","volume":"125","author":"Telgenhoff","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2020.106255_b0105","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0206-z","article-title":"Induction and transcriptional regulation of the co-inhibitory gene module in T cells","volume":"558","author":"Chihara","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2020.106255_b0110","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1084\/jem.20151118","article-title":"Protein C receptor (PROCR) is a negative regulator of Th17 pathogenicity","volume":"213","author":"Kishi","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2020.106255_b0115","doi-asserted-by":"crossref","first-page":"S298","DOI":"10.1097\/01.CCM.0000126128.64614.81","article-title":"Structure and functions of the endothelial cell protein C receptor","volume":"32","author":"Esmon","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2020.106255_b0120","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1172\/JCI31027","article-title":"Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease","volume":"117","author":"Scaldaferri","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2020.106255_b0125","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1097\/01.CCM.0000128032.85396.83","article-title":"Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease","volume":"32","author":"Faioni","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2020.106255_b0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/rheumatology\/kep034","article-title":"Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis","volume":"48","author":"Izmirly","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2020.106255_b0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/s10165-008-0143-z","article-title":"Effect of disease activity and corticosteroids on serum levels of soluble endothelial cell protein C receptor in patients with systemic lupus erythematosus","volume":"19","author":"Koarada","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106255_b0140","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/key429","article-title":"Activated protein C targets immune cells and rheumatoid synovial fibroblasts to prevent inflammatory arthritis in mice","author":"Xue","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2020.106255_b0145","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar4473","article-title":"Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2","volume":"16","author":"Xue","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2020.106255_b0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13075-015-0859-z","article-title":"Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways","volume":"17","author":"Liu","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2020.106255_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.89","article-title":"In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis","volume":"45","author":"Moon","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2020.106255_b0160","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2007.083360","article-title":"Interleukin 27 attenuates collagen-induced arthritis","volume":"67","author":"Niedbala","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2020.106255_b0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biopha.2017.03.026","article-title":"Therapeutic effect of quercetin in collagen-induced arthritis","volume":"90","author":"Haleagrahara","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2020.106255_b0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/ar14","article-title":"Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis","volume":"1","author":"Joosten","year":"1999","journal-title":"Arthritis Res."},{"key":"10.1016\/j.intimp.2020.106255_b0175","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1182\/blood-2007-08-104968","article-title":"Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma","volume":"111","author":"Saposnik","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.106255_b0180","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1074\/jbc.275.8.6038","article-title":"Metalloproteolytic release of endothelial cell protein C receptor","volume":"275","author":"Xu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2020.106255_b0185","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1182\/blood-2012-08-452169","article-title":"Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46","volume":"120","author":"Mosnier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.106255_b0190","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1538-7836.2012.04825.x","article-title":"Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects","volume":"10","author":"Schuepbach","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2020.106255_b0195","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00018-011-0825-0","article-title":"The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling","volume":"69","author":"Gleeson","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2020.106255_b0200","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood-2016-06-720581","article-title":"Occupancy of human EPCR by protein C induces beta-arrestin-2 biased PAR1 signaling by both APC and thrombin","volume":"128","author":"Roy","year":"2016","journal-title":"Blood"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919321502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919321502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:21:20Z","timestamp":1761585680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919321502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":40,"alternative-id":["S1567576919321502"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106255","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated levels of soluble Endothelial protein C receptor in rheumatoid arthritis and block the therapeutic effect of protein C in collagen-induced arthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106255"}}